Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

Affiliations

• ¹ Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, CBI 8RN, UK. [email protected].
• ² Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, CBI 8RN, UK.
• ³ Department of Epidemiology, Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands.
• ⁴ Department of Medical Oncology, Family Center Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
• ⁵ DASC, Oncogénétique Clinique, Institut Paoli-Calmettes, Marseille, France.
• ⁶ Institut Curie, Service de Génétique, Paris, France.
• ⁷ Département de Médecine Oncologique, Gustave Roussy Hôpital Universitaire, Villejuif, France.
• ⁸ Centre Hospitalier, Service Régional d'Oncologie Génétique Poitou-Charentes, Niort, France.
• ⁹ Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France.
• ¹⁰ Centre Catherine de Sienne, Service d'Oncologie Médicale, Nantes, France.
• ¹¹ Genomic Medicine, Manchester Academic Health Sciences Centre, Division of Evolution and Genomic Sciences, Manchester University, Central Manchester, University Hospitals NHS Foundation Trust, Manchester, UK.
• ¹² Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
• ¹³ Yorkshire Regional Genetics Service, Chapel Allerton Hospital and University of Leeds, Leeds, UK.
• ¹⁴ Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.
• ¹⁵ Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, UK.
• ¹⁶ Academic Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.
• ¹⁷ Institute of Genetic Medicine, Centre for Life, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK.
• ¹⁸ Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK.
• ¹⁹ University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK.
• ²⁰ Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
• ²¹ Department of Gynaecological Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
• ²² Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
• ²³ Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
• ²⁴ Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, 3010, Australia.
• ²⁵ Department of Medicine and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
• ²⁶ Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, NY, USA.
• ²⁷ Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA.
• ²⁸ Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
• ²⁹ Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
• ³⁰ Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
• ³¹ Department of Medicine, Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT, USA.
• ³² Human Genetics Group and Genotyping Unit, CEGEN, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
• ³³ Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, CIBERONC (ISCIII), Madrid, Spain.
• ³⁴ Department of Genetics and Pathology, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, Poland.
• ³⁵ Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, Poland.
• ³⁶ Genomics Center, Centre Hospitalier Universitaire de Québec, Université Laval Research Center, 2705 Laurier Boulevard, Quebec City, Quebec, Canada.
• ³⁷ Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, A 1090, Vienna, Austria.
• ³⁸ Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
• ³⁹ Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Zluty kopec 7, 65653, Brno, Czech Republic.
• ⁴⁰ Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
• ⁴¹ The Department of Oncology and Pathology, Karolinska Institute, 171 76, Stockholm, Sweden.
• ⁴² Department of Oncology, Lund University Hospital, Lund, Sweden.
• ⁴³ Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
• ⁴⁴ Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
• ⁴⁵ Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
• ⁴⁶ Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
• ⁴⁷ National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.
• ⁴⁸ German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.
• ⁴⁹ The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
• ⁵⁰ Department of Medical Oncology Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St, East Melbourne, Victoria, 8006, Australia.
• ⁵¹ Department of Epidemiology, Columbia University, New York, NY, USA.
• ⁵² Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
• ⁵³ Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
• ⁵⁴ Department of Dermatology, University of Utah School of Medicine, 30 North 1900 East, SOM 4B454, Salt Lake City, UT, 841232, USA.
• ⁵⁵ INSERM, U900, Paris, France.
• ⁵⁶ Institut Curie, Paris, France.
• ⁵⁷ Mines Paris Tech, Fontainebleau, France.
• ⁵⁸ PSL Research University, Paris, France.
• ⁵⁹ Centre for Cancer Genetic Epidemiology, Department of Oncology, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, CBI 8RN, UK.